
First Human Trial Begins for New Bundibugyo Ebola Vaccine
The first human trial for an experimental vaccine targeting the Bundibugyo strain of Ebola has commenced, with a volunteer in the UK receiving the initial dose. This development comes as Ebola cases in DR Congo continue to rise, reaching 2,905.
The Story
Analyzing sources…
Source Diversity
Source Diversity
Excellent (92/100)Sources
First person gets new experimental vaccine for Ebola
Ed Hunt, 37 and from the UK, voluteered after seeing news reports of the deadly Ebola outbreak in DR Congo.
Read full article →Ebola virus: first person vaccinated in UK trial of new jab
A volunteer was injected on Friday with the first dose of a rapidly developed vaccine targeting the Bundibugyo strain of Ebola driving a deadly outbreak in the Democratic Republic of Congo (DRC), Oxford University said. More than 1,000 people have been killed in the DRC and Uganda since the outbreak emerged in May, according to the World Health Organization. Researchers and health organisations have since been racing to get a vaccine or treatment for the relatively rare strain to the clinical...
By Agence France-Presse
Read full article →CEPI begins first human trial of Bundibugyo Ebola vaccine
The Phase I clinical trial, known as BD-Ebov, will evaluate the safety of the experimental vaccine and its ability to stimulate immune responses in healthy adult volunteers. The post CEPI begins first human trial of Bundibugyo Ebola vaccine appeared first on Premium Times Nigeria.
By Agency Report
Read full article →First person gets new experimental vaccine for Ebola
The first volunteer in the world - a 37-year-old UK man called Ed Hunt - has received an experimental vaccine against the Ebola virus.
By Deborah Okailey Quarcoo
Read full article →
